SHL to join 2019 Contracting and Outsourcing Conference

Press Release 201908 Outsource

SHL will exhibit at the 2019 Contracting and Outsourcing Conference & Tabletop Exhibition on September 26 in New Brunswick, New Jersey. For this two-day conference, the company is set to showcase its quality offerings in final assembly, labeling and packaging at the one-day tabletop exhibition.

SHL is looking forward to providing our insights on the CMO/CDMO industry to pharma companies at the event. SHL’s experts will be on-site to offer their expertise on the company’s vertically integrated services, including packaging and labeling. Conference talks will focus on regulatory challenges in drug packaging and global trends in outsourcing markets.

As one of the industry leaders in drug delivery product design and manufacturing, SHL has invested heavily in recent years to establish a contract manufacturing service offering final assembly, labeling and packaging for SHL-designed devices. Business Development Manager Jamie Gould said, “SHL is committed to providing the best possible solutions for our customers in the final process of device development. This event provides us with a great opportunity to network with people and expand our scope in the pharmaceutical packaging industry.”

To learn more, visit SHL at the Hyatt Regency in New Jersey on September 26.

About SHL

SHL Group is a world-leading solutions provider in the design, development, and manufacturing of advanced drug delivery devices such as autoinjectors, pen injectors and advanced inhaler systems. We also offer core competencies and services in the fields of medtech and patient care solutions. With locations in Taiwan, Switzerland, Sweden, China and the US, our experienced engineers and designers develop product enhancements as well as breakthrough drug delivery and patient care solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of next-generation drug delivery systems that support ongoing innovations in drug development and digital healthcare. This includes advanced reusable and disposable injectors that can accommodate high volume and high viscosities and can be enhanced through digital implementations.

With over 4,800 employees worldwide, SHL Group consists of several distinct group companies:

SHL Medical designs, develops and manufactures advanced drug delivery devices, as well as provides final assembly, labeling and packaging services for leading pharmaceutical and biotech companies across the globe.

SHL Healthcare develops and manufactures equipment solutions for home, hospital and long term care use.

SHL Technologies provides contract manufacturing and engineering services for the production of complex medtech and industrial products.

For additional information, visit

Media contact:


Related News